Highlights Thermo Fisher Scientific, Inc.

Equities

TMO

US8835561023

Advanced Medical Equipment & Technology

Market Closed - Nyse Other stock markets 04:00:02 2025-12-04 pm EST			5-day change	1st Jan Change
575.24 ^USD	-0.90%		-3.04%	+10.57%

Dec. 04	GENinCode inks commercialisation deal with Thermo Fisher	AN
Dec. 04	GENinCode Partners with US-based Thermo Fisher to Commercialize Heart Disease Test	MT

Highlights

GENinCode inks commercialisation deal with Thermo Fisher	Dec. 04	AN
GENinCode Partners with US-based Thermo Fisher to Commercialize Heart Disease Test	Dec. 04	MT
Thermo Fisher Scientific Announces Expansion of Bioprocess Design Centers in Asia to Support Biopharma Innovation	Dec. 02	CI
Thermo Fisher Scientific Prices Offering of Euro-Denominated Notes at 100% of Par Value	Nov. 25	MT
Thermo Fisher Scientific's Oncomine Dx Target Test Receives FDA Approval as a Companion Diagnostic to Identify Patients Eligible for Newest Targeted Therapy for Non-Small Cell Lung Cancer	Nov. 20	CI
Thermo Fisher Scientific Introduces Thermo Scientific?? Suretect?? Beverage Spoilage Multiplex Qpcr Assay	Nov. 19	CI
Thermo Fisher Scientific Opens East Coast Collaboration Center At BioLabs for Advanced Therapeutics to Help Accelerate Cell and Gene Therapy Development	Nov. 18	CI
Thermo Fisher Scientific Inc. Launches CorEvitas Clinical Registry in Myasthenia Gravis, A Rare Autoimmune Disorder	Nov. 17	CI
Thermo Fisher Scientific Receives 510(K) Clearance in the United States for EXENT System to Aid in the Diagnosis of Multiple Myeloma	Nov. 12	CI
Thermo Fisher Scientific Says US FDA Clears Exent System for Multiple Myeloma Diagnosis	Nov. 12	MT
Thermo Fisher Scientific Insider Sold Shares Worth $5,844,850, According to a Recent SEC Filing	Nov. 10	MT
Thermo Fisher Scientific authorizes $5 billion of share repurchases	Nov. 06	RE
Thermo Fisher Scientific Plans $5 Billion Share Repurchase Program, Maintains Quarterly Dividend	Nov. 06	MT
Thermo Fisher Scientific Inc. announces an Equity Buyback for $5,000 million worth of its shares.	Nov. 06	CI
Thermo Fisher Scientific Inc. Declares Quarterly Cash Dividend, Payable on January 15, 2026	Nov. 06	CI
Thermo Fisher Scientific Inc. authorizes a Buyback Plan.	Nov. 05	CI
Waters Corp raises annual profit forecast on stronger lab equipment demand	Nov. 04	RE
Partners Group Private Equity to Divest Clario Business to Thermo Fisher Scientific	Nov. 03	MT
PGPE announces sale of Clario stake to Thermo Fisher Scientific	Nov. 03	AN
Partners Group Private Equity announces sale of Clario to Thermo Fisher Scientific	Nov. 03	RE
Tranche Update on Thermo Fisher Scientific Inc.'s Equity Buyback Plan announced on November 15, 2024.	Oct. 31	CI
A Shot in the Dark	Oct. 29
Thermo Fisher to Acquire Clario for About $8.88 Billion in Cash Plus Potential Earnouts	Oct. 29	MT
Thermo Fisher Scientific Inc. entered into a definitive agreement to acquire Clario Holdings, Inc. from a shareholder group led by Nordic Capital, Novo Holdings A/S, Astorg Asset Management S A.R.L., Cinven Limited and Partners Group Private Equity Limited, managed by Partners Group Holding AG for $9.4 billion.	Oct. 29	CI
Thermo Fisher Scientific Agrees to Buy Clario Holdings for $8.88 billion	Oct. 29	DJ

No results for this search

All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Filters

Headlines

Thermo Fisher opens the biotech ball with a bang

July 25, 2024 at 10:56 am EDT